JAK-inhibitor
Leo Pharma reveals positive results for its JAK cream in hand eczema, competing with Incyte’s Opzelura
Anika Sharma
In February, Leo Pharma created a buzz by announcing the success of its JAK-inhibitor cream, delgocitinib, in a phase 3 ...
